Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Evogene Q1 EPS $(0.38) Beats $(0.63) Estimate, Sales $2.44M Miss $4.42M Estimate

Author: Benzinga Newsdesk | May 21, 2025 06:01am
Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.63) by 39.68 percent. This is a 50 percent increase over losses of $(0.76) per share from the same period last year. The company reported quarterly sales of $2.44 million which missed the analyst consensus estimate of $4.42 million by 44.67 percent. This is a 41.67 percent decrease over sales of $4.19 million the same period last year.

Posted In: EVGN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist